NYSE - Nasdaq Real Time Price USD

NeueHealth, Inc. (NEUE)

6.76
+0.11
+(1.65%)
At close: May 9 at 4:00:02 PM EDT
6.76
-0.01
(-0.08%)
After hours: May 9 at 4:05:13 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
936,657
936,657
1,160,802
751,163
1,513,033
Cost of Revenue
742,140
742,140
996,582
662,972
1,294,158
Gross Profit
194,517
194,517
164,220
88,191
218,875
Operating Expense
289,546
289,546
305,434
385,146
562,502
Operating Income
-95,029
-95,029
-141,214
-296,955
-343,627
Net Non Operating Interest Income Expense
-18,701
-18,701
-38,203
-12,822
-7,230
Other Income Expense
14,269
14,269
-449,753
-71,801
1,226
Pretax Income
-99,461
-99,461
-629,170
-381,578
-349,631
Tax Provision
2,597
2,597
-1,428
3,664
-26,521
Net Income Common Stockholders
-186,330
-186,330
-1,200,599
-1,495,231
-1,184,862
Diluted NI Available to Com Stockholders
-186,330
-186,330
-1,200,599
-1,495,231
-1,184,862
Basic EPS
-22.65
--
-150.94
-190.40
-241.60
Diluted EPS
-22.65
--
-150.94
-190.40
-241.60
Basic Average Shares
8,226
--
7,954
7,853.10
4,903.04
Diluted Average Shares
8,226
--
7,954
7,853.10
4,903.04
Total Operating Income as Reported
-107,410
-107,410
-576,996
-368,756
-343,627
Total Expenses
1,031,686
1,031,686
1,302,016
1,048,118
1,856,660
Net Income from Continuing & Discontinued Operation
-134,680
-134,680
-1,151,454
-1,455,544
-1,184,862
Normalized Income
-148,293.51
-148,293.51
-64,655.78
-424,183.21
-329,607
Interest Expense
18,701
18,701
38,203
12,822
7,230
Net Interest Income
-18,701
-18,701
-38,203
-12,822
-7,230
EBIT
-80,760
-80,760
-590,967
-368,756
-342,401
EBITDA
-65,114
-65,114
-566,800
-318,181
-306,917
Reconciled Cost of Revenue
742,140
742,140
990,711
643,107
1,293,723
Reconciled Depreciation
15,646
15,646
24,167
50,575
35,484
Net Income from Continuing Operation Net Minority Interest
-137,021
-137,021
-513,388
-480,906
-329,607
Total Unusual Items Excluding Goodwill
14,269
14,269
-449,753
-71,801
0
Total Unusual Items
14,269
14,269
-449,753
-71,801
0
Normalized EBITDA
-79,383
-79,383
-117,047
-246,380
-306,917
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
2,996.49
2,996.49
-1,020.78
-15,078.21
0
12/31/2021 - 6/24/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers